AEGLEA BIOTHERAPEUTICS INC (AGLE)

US00773J2024 - Common Stock

12.01  +0.97 (+8.79%)

After market: 11.88 -0.13 (-1.08%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.06M2.33M18.74M0.000.00
Operating Expenses
221.54M87.11M84.39M81.48M80.33M
Research and Development
195.23M58.58M57.07M59.64M64.60M
Selling, General, and Administrative Expenses
26.33M28.53M27.32M21.84M15.73M
Operating Income
-220.50M-84.78M-65.65M-81.48M-80.33M
Interest Income/Expense
-81.10M840.00K110.00K590.00K2.14M
Other Income/Expense
17.14M-10.00K-120.00K-10.00K-60.00K
Income Before Taxes
-294.41M-83.95M-65.66M-80.89M-78.25M
Income Tax
10.00K-140.00K140.00KN/AN/A
Net Income
-294.43M-83.82M-65.80M-80.89M-78.25M
EBITDA
N/A-83.21M-64.07M-80.48M-79.91M
 
Per Share Data
EPS Diluted Total Ops
-75.98-24.86-25.02-37.97-61.13
Non GAAP EPS
-60.34-25.25-8.44-1.61-2.45
 
Statistics
Profit Margin
-27776.42%-3597.42%-351.12%N/AN/A
Operating Profit Margin
-20801.89%-3638.63%-350.32%N/AN/A

All data in USD

Charts